How Does Aevis Victoria Company Actually Work?

Aevis Victoria SA operates Swiss Medical Network hospitals and clinics focusing on acute care, orthopedics, cardiology, and oncology, plus a strategic shift toward high-margin outpatient and day-surgery hubs to raise utilization and margins.

Through MRH Switzerland the group sells premium hotel stays at landmark properties in Zermatt, Lucerne, and Geneva, targeting high average room rates (ARR) from international leisure and business travelers.

Infracore SA and Swiss Hotel Properties SA deliver medical and hotel real estate as stabilized assets that produce predictable, long-term rental yields and support clinical and hospitality operations.

Clients include private patients and insurers for acute and elective care, high-net-worth and corporate hotel guests, and institutional investors seeking yield from healthcare and hotel property leases.

Customers get premium clinical outcomes and convenience from specialist clinics, upscale hospitality with high ARR, and investors access to stable rental yields from purpose-built medical and hotel real estate.

Clients choose Aevis Victoria for integrated healthcare-hospitality scale, premium locations (Zermatt, Lucerne, Geneva), specialist medical teams, and a diversified revenue model that blends fee-for-service healthcare income with high-ARR hotel revenue and asset-backed lease income; see market positioning in Who Aevis Victoria Company Competes With.

Swiss Medical Network produced gross revenues of CHF 988.5 million in 2025 by billing medical fees and receiving reimbursements from Swiss health insurers; this clinical fee-for-service base anchors Aevis Victoria SA's cash flow and scale.

The hotel and resort portfolio posted CHF 195.4 million in 2025 revenue, driven by room sales and premium MICE packages with an average room rate of CHF 581, supplying both seasonal cash and higher margin event income.

Real estate subsidiaries provide stable rental cash flows: Swiss Hotel Properties recorded CHF 46.0 million in 2025 income and Infracore reported CHF 66.4 million in revenues excluding revaluations, supporting earnings visibility.

Aevis Victoria's mix combines fee-for-service medical billing, per-night and package hotel pricing (including premium MICE add-ons), and contractual rental agreements; revenues are therefore a mix of transaction-based and recurring contractual cash flows.

The most important driver is clinical volume and insurer reimbursement rates for Swiss Medical Network, followed by occupancy and average daily rate (ADR) for hotels, and lease stability for the real estate arm.

Revenue sensitivity centers on patient throughput and tariff changes in healthcare, ADR and MICE booking cadence in hospitality, and lease renewals or indexation in real estate-each affects Aevis Victoria investments differently.

Aevis Victoria benefits from a high-quality Swiss real estate portfolio that underpins NAV and liquidity, while its integrated care approach (Viva health plan and clinic operations) creates a captive referral ecosystem that reduces clinic vacancy and supports cross-selling between hospitals and hotels.

Scale in Swiss healthcare and hospitality, plus expansion into the Aare – Netz integrated care region in 2025, strengthens referral flows and fills clinical capacity; deleveraging reduced net debt by CHF 113.3 million in 2025, lowering leverage to 49.8 percent.

The model depends on Swiss healthcare reimbursement stability and demand for luxury medical and hotel services; policy shifts or weaker cross – border patient flows could quickly reduce revenue per clinic and occupancy rates.

AEVIS VICTORIA SA reported a consolidated loss of CHF 25.6 million in 2025, driven by heavy growth investments and a temporary absence of M&A gains, leaving margins tight and debt service sensitive until operating cash flow improves.